AUG 1, 2026 · JOURNAL ARTICLE
Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF)
Journal of the American College of Cardiology
Well-designed RCT with clear primary endpoint showing natriuretic peptide screening identifies unrecognized HF in diabetes at high frequency with robust effect size, though clinical outcomes and longer-term follow-up remain unreported.
Reported
Primary endpoint: HF diagnosis at…87/354 (24.6%)
Primary endpoint: HF diagnosis at…2/352 (1%)
Odds ratio for HF diagnosis58